BMO Capital upgraded Merck (NYSE: MRK) from Market Perform to Outperform with a price target of $70.00 (from $65.00) as ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE